APTV · 10-Q · 2026Q3 · Full report

Capital Return Program

Aptiv PLC · 2026-11-03 · Importance 69 · Surprise 64 · In source text

Aptiv paid $558 million to repurchase ordinary shares during the nine months ended September 30, 2026, compared with $96 million in the same 2025 period. Financing activities also included $282 million of cash transferred to Versigent in connection with the spin-off and a $1.893 billion cash dividend received from Versigent. The 2026 financing cash uses additionally included $2.054 billion of senior-note repayments, while net cash used in financing activities totaled $1.039 billion, compared with $843 million in 2025.

Key facts

• Aptiv’s July 2024 share-repurchase program authorized purchases of up to $5.0 billion of ordinary shares and commenced in August 2024. source
• Aptiv had approximately $1.557 billion remaining under its July 2024 share-repurchase program as of September 30, 2026. source
• Aptiv repurchased an additional $58 million of shares from October 1 to November 2, 2026, leaving approximately $1.499 billion available under the July 2024 program. source
• Aptiv repurchased approximately 9.8 million ordinary shares for $558 million in the open market during the nine months ended September 30, 2026. source
• Aptiv expected to continue repurchasing ordinary shares under its authorized share-repurchase program. source

Impact estimates